Clinical trial · Interventional
Brief Title- Virtual Reality Glasses in Gynecologic Cancer
The Effect of Virtual Reality Glasses Used in Gynecologic Cancer Patients Receiving Chemotherapy on Treatment Compliance and Anxiety Level.
NCT06760689CI-TRIAL-00084395enrolling by invitationN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
It was planned to determine the effect of virtual reality glasses used in female patients diagnosed with gynecological cancer and receiving chemotherapy on treatment compliance and anxiety level. The study has a single-center, randomized controlled experimental design.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Anxiety | — | UNRESOLVED | — |
| Gynecologic Cancers | Malignant Female Reproductive System Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| scale | Other | — | UNRESOLVED |
| virtual reality glasses | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Experimental group
- description
- The patient was given detailed information about the research and intervention, and written consent was obtained with an informed voluntary consent form. The patient's information was obtained through the descriptive information form containing sociodemographic information.The same ways were applied for 1,2,3 cures. The researcher applied the pre-test State and Trait Anxiety Scale, and the Chronic Disease Adaptation Scale (CHSS) to the patient.The patient was directed to move to the room designated by the nurse in the outpatient unit. Before the chemotherapy course began, the patient was shown the content that the patient could watch through virtual reality glasses on the phone.He was asked to choose one of them.The patient watched a video of his/her choice with the virtual reality glasses application (20 min). At the end, the glasses were removed. Afterwards, the State and Trait Anxiety Scale and the Chronic Diseases Adjustment Scale (CHAS) were applied.
- interventionNames
- Device: virtual reality glasses
- Other: scale
- type
- ACTIVE_COMPARATOR
- label
- control group
- description
- The pre-test State and Trait Anxiety Scale and Chronic Disease Adjustment Scale (CHAS) were applied to the patient by the researcher. The patient was directed to the room determined by the nurse in the outpatient treatment unit. The patient's chemotherapy infusion started.The patient received standard nursing care. After 30 minutes, the State and Trait Anxiety Scale and the Chronic Diseases Adjustment Scale (CHAS) were administered.
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 65 Years
Show eligibility criteria text
Inclusion Criteria: * Being over 18 years old. * Stage 1-2-3 * Knowing the disease diagnosis * Knowing how to read and write in Turkish * No history of seizures * No cranial metastasis * Not diagnosed with a psychiatric disorder, no dementia * Those who receive their treatment in 21-day periods to ensure equality in application frequencies * Able to use virtual reality glasses * No visual or hearing impairment * Volunteer patients Exclusion Criteria: * Stage 4 * Those with vertigo * Those with hyperemesis during pregnancy * Those who experience nausea and vomiting during travel * Those with visual and hearing impairment * Patients who do not know their cancer diagnosis, have been diagnosed with cancer but have not received treatment or have completed their cure
References
Publications (0)
Data not yet available
No reference posted for this study.